Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Featured Stories

FDA Will No Longer Regulate Certain Medical Software

The US agency published a final rule on 16 April that says eight medical software functions will no longer be classified as medical devices. The rule finalizes a statutory provision from the 21st Century Cures Act.

Regulation Digital Health FDA

Prescience Point Capital Launches Proxy Fight To Change MiMedx's Board

Prescience Point Capital is trying to reshuffle the board of directors leading regenerative medicine company MiMedx, arguing the company’s current board has destroyed shareholder value. The company's tock is selling for about a third of its potential value, according to Prescience.

Medical Device Commercial Deals

Submitting A Non-COVID-19 Product For FDA Review? Then Take A Seat, It’s Gonna Be Awhile

Top US FDA device center officials Jeff Shuren and William Maisel said in a 15 April blog post that manufacturers should expect a delay in the review of new product submissions thanks to the pandemic. They noted that the agency also won’t be accepting certain IVD pre-submission requests until next year.

FDA Review Pathway Coronavirus COVID-19

Turkish Medtechs Face The Constant Challenge Of Sailing In Stormy Seas

The pandemic has exacerbated the problems of the Turkish medical device industry, which was already struggling for survival and growth in a hostile policy environment. Local blood bag manufacturer Kansuk Laboratory talked to Medtech Insight about the difficulties it faces.

Turkey Policy Government Payers

Spotlight On Case Studies

Lucira Health’s Unexpected Sprint To A First-Of-Its-Kind EUA From FDA: The Inside Story

Lucira Health executive VP Kelly Brezoczky explains in this Medtech Insight case study how the company shifted gears from making a test for influenza A and B to quickly developing one that detected SARS-CoV-2. The result was the company’s COVID-19 All-In-One Test Kit, an at-home prescription molecular diagnostic test that was the first of its type to hit the market when the US FDA granted it emergency use authorization last November.

Diagnostics Review Pathway

Facts And Figures Show It Is Essential To Better Manage The EU IVDR Peak: But How?

No one should underestimate the scale of the obstacles companies face trying to comply in time with the IVD Regulation by its 26 May 2022 deadline, especially now data is starting to emerge to highlight the size of the problem.

Europe EU Medical Device

US FDA: Recall Of BD Alaris Infusion Pump Is High-Risk Class I

Becton Dickinson’s CareFusion 303 Inc. subsidiary recalled 145,492 of the pumps because there’s a risk that the device’s keypad will lift up and away from the device body if it comes into contact with fluids.

Recalls Safety FDA

US FDA Nukes HHS Decision To Exempt Medical Gloves, Other Products From Regulatory Oversight

The agency has rescinded two previous notices issued by HHS, stating the FDA had no input on the notices before they were published and the rationale backing them was flawed.

Regulation Policy Compliance

Device Week Podcast

In This Episode:Reimbursement Dispute Between Novitas And iRhythm Hits An Impasse

Listen to Medtech Insight podcasts for our perspectives on regulation, policy, quality, R&D and key commercial topics.

More Podcasts

Recent Tweets from Medtech Insight

Latest from PR Newswire


Click here to access further medical device and diagnostics news.


 

Policy & Regulation Explore this Topic

Set Alert for Policy & Regulation

12 Deaths Prompt Another Class I Recall For Medtronic’s HeartWare – The Firm’s Fourth In Recent Weeks

The medtech giant has racked up yet another high-risk class I recall designation from the US FDA, this time for HeartWare Ventricular Assist Device (HVAD) cables and controller ports. It’s also the second class I recall action for the HeartWare device in a little more than six weeks, and the company’s fourth overall.

Recalls Safety FDA

It’s COVID-19 ‘Clean-Up Time’: FDA, Health Canada Hint At What’s Next In Enforcement

American and Canadian regulators have taken stock of their enforcement activities in the first year of the pandemic, and now they’re focused on what’s coming next.

Enforcement United States Canada

Latest From Policy & Regulation

US Sen. Duckworth Prods FEMA To Help Overstocked PPE Reach Potential Users

The Illinois senator pointed to an apparent mismatch between ongoing reports of equipment shortages, and alleged stockpiles of unsold masks.

Coronavirus COVID-19 Policy

TEAM-NB Highlights Survey Figures Suggesting Massive 2024 Bulge In MDR Applications

Growing evidence demonstrates the one-year delay to the Medical Device Regulation, plus the expansion of the scope of products that could remain on the market beyond the MDR date of application, have simply pushed problems to 2024.

Europe EU

FDA’s 5 Steps To A Successful ASCA Pilot Submission

Sponsors participating in the US FDA’s Accreditation Scheme for Conformity Assessment pilot program should work closely with the lab and be prepared for a few extra steps in putting a submission together, agency staff say.

International FDA

US Lawmakers Reintroduce Bill To Better Patient Access To Prosthetic Devices, Other Limb-Loss Technologies

The bipartisan Triple A Study Act directs the Government Accountability Office to report back to Congress on the coverage of assistive technologies for people with limb loss or limb difference.

Legislation Orthopedics

Device Week, 14 April 2021 – Mayo Clinic, VHA Big On 3D Printing; Ortho Market

In this week’s podcast, Medtech Insight managing editor Marion Webb discusses plans by the Mayo Clinic and Veterans Health Administration to position themselves as medical device makers of 3D-printing technologies. UK-based reporter Barnaby Pickering gives an overview of global market for arthroscopy and sports medicine products.

Digital Health Device Week

FDA Authorizes GI Genius As A Smarter AI-Based Colonoscopy Tool

According to a large clinical study, the first such device with AI-enabled software is better at detecting potential lesions than traditional colonoscopies and could allow detection of colon cancer sooner.

Research & Development Regulation

Quality Control & Compliance Explore this Topic

Set Alert for Quality Control

Latest From Quality Control

TEAM-NB Highlights Survey Figures Suggesting Massive 2024 Bulge In MDR Applications

Growing evidence demonstrates the one-year delay to the Medical Device Regulation, plus the expansion of the scope of products that could remain on the market beyond the MDR date of application, have simply pushed problems to 2024.

Europe EU

Another Class I Recall For Medtronic, This Time For Defibrillators

The US FDA on 12 April affixed its highest risk classification to a recall of certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) made by Medtronic. It’s the third class I recall for the medtech giant since 1 March.

Recalls Safety

FDA Plans To Improve COVID-19 EUA Process, Inspection Work Based On Report Recommendation

The agency is taking to heart several recommendations made by an independent reviewer earlier this year in a report on its COVID-19 response.

FDA Compliance

OUTLOOK 2021

Forward-looking features and special content, including Scrip 100, Medtech 100 and Generics Top 50 industry rankings

VIEW NOW

Commercial Explore this Topic

Set Alert for Commercial

Surgical Robotics Company Vicarious Surgical To Merge With D8 SPAC In $1.1Bn Deal

Vicarious Surgical, whose medical robot received US FDA breakthrough designation, announced it will merge with D8 Holdings Corp. The deal is expected to garner up to $460m.

Commercial Financing M & A

Latest From Commercial

Execs On The Move: Repro-Med Replaces Its CEO

At Repro-Med, James Beck has been replaced by Linda Tharby as CEO, and more.

Commercial Companies

Mayo Clinic Launches Two Companies To Support New Remote Monitoring Initiative

The Minnesota-based health care system announced the formation of Anumana Inc. to commercialize artificial intelligence-enabled algorithms and Lucem Health to curate data collected from remote monitoring devices.

Digital Health Financing

MD&M BIOMEDigital 2021: Wearables – Where Are They Headed?

As wearable medical devices become increasingly common for more and more complex applications, developers are facing questions are about the industry’s direction and how they will protect consumers.

Digital Health Consumer

Device Week, 14 April 2021 – Mayo Clinic, VHA Big On 3D Printing; Ortho Market

In this week’s podcast, Medtech Insight managing editor Marion Webb discusses plans by the Mayo Clinic and Veterans Health Administration to position themselves as medical device makers of 3D-printing technologies. UK-based reporter Barnaby Pickering gives an overview of global market for arthroscopy and sports medicine products.

Digital Health Device Week

Luminex Will Be Acquired By DiaSorin For About $1.8Bn

The buyout will broaden DiaSorin’s positioning in the fast-growing molecular diagnostics space and expand Luminex’s foothold outside the US.

Financing Diagnostics

Reimbursement Dispute Between Novitas And iRhythm Hits An Impasse

Local Medicare carrier Novitas raised its reimbursement rates for continuous cardiac monitoring, but iRhythm has concluded the rates are still too low and is preparing to discontinue serving this Medicare segment.

Reimbursement Cardiovascular

Clinical R&D Explore this Topic

Set Alert for Clinical R&D

Start-Up Spotlight: Pre Diagnostics Picks Up Momentum In Early Neurodegenerative Disease Detection

Norway’s Pre Diagnostics uses the intracellular approach to neurodegenerative disease diagnosis. It believes its technology will open up a world of precision medicine for Alzheimer’s disease patients.

Start-up Spotlight In Vitro Diagnostics Neurology

Latest From Research & Development

Mayo Clinic Launches Two Companies To Support New Remote Monitoring Initiative

The Minnesota-based health care system announced the formation of Anumana Inc. to commercialize artificial intelligence-enabled algorithms and Lucem Health to curate data collected from remote monitoring devices.

Digital Health Financing

FDA’s 5 Steps To A Successful ASCA Pilot Submission

Sponsors participating in the US FDA’s Accreditation Scheme for Conformity Assessment pilot program should work closely with the lab and be prepared for a few extra steps in putting a submission together, agency staff say.

International FDA

MD&M BIOMEDigital 2021: Wearables – Where Are They Headed?

As wearable medical devices become increasingly common for more and more complex applications, developers are facing questions are about the industry’s direction and how they will protect consumers.

Digital Health Consumer

Luminex Will Be Acquired By DiaSorin For About $1.8Bn

The buyout will broaden DiaSorin’s positioning in the fast-growing molecular diagnostics space and expand Luminex’s foothold outside the US.

Financing Diagnostics

FDA Authorizes GI Genius As A Smarter AI-Based Colonoscopy Tool

According to a large clinical study, the first such device with AI-enabled software is better at detecting potential lesions than traditional colonoscopies and could allow detection of colon cancer sooner.

Research & Development Regulation

Italian Orthopedics Company Greenbone OrthoSpA Raises €10M In Series B

Greenbone will use the proceeds to launch its CE-marked bone regeneration scaffold and plans to file for 510(k) FDA clearance.

Financing Orthopedics
UsernamePublicRestriction

Register